Journal of Cardiac Failure

Papers
(The H4-Index of Journal of Cardiac Failure is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Outcomes Of Hospitalization In Patients With Diastolic Heart Failure Undergoing Hematopoietic Stem Cell Transplant (HSCT): A National Inpatient Sample Analysis (2002-2019)682
Electrolyte Variability During Acute Decompensated Heart Failure Hospitalization396
Efficacy And Safety Of Intravenous Iron In Patients With Iron Deficiency Anemia And Heart Failure With Reduced Ejection Fraction. A Systematic Review And Meta-analysis89
Weight Loss Management By A Pharmacist To Overcome Obesity As A Barrier To Surgical Advanced Heart Failure Interventions87
Proteomic Correlates Of Urinary Protein Creatinine Ratio In Heart Failure With Preserved Ejection Fraction84
Psoas Muscle Index As An Independent Risk Factor Predictive Of Increased Post Operative Length Of Stay In Orthotopic Heart Transplant Candidates79
Prognostic Value Of Percentage Of Predicted Peak Oxygen Consumption Using Functional Aerobic Impairment And Friend Equations In Patients With Heart Failure With Reduced Ejection Fraction75
Effect Of Mavacamten On Echocardiographic Parameters In Patients With Obstructive Hypertrophic Cardiomyopathy: A Real World Cohort71
Readmission Rate And Hospitalization Costs In HFpEF In Patients With OSA68
Methodological Quality Of Clinical Practice Guidelines In Heart Failure: A Systematic Critical Appraisal Using The Agree II Tool67
Synchronized Diaphragmatic Stimulation As A Potential Outpatient Implant Procedure For HfrEF Therapy63
A Resident-led Initiative To Improve Heart Failure Readmission Rate By Targeting Factors Of Social Vulnerability61
Heartfelt Advances: ACC 2024 Clinical Trials Spotlight—New Horizons in Heart Failure Management60
JCF Heart Failure Year-In-Review 2023… Shaping the Future of Heart Failure58
Improving ATTR-CM Detection: Targeting Populations With the Greatest Need57
Development And Implementation Of An Rv Stress Test To Assess Rv Reserve Pre-lvad55
Masthead51
The Swan is not the Ugly Duckling50
COUNTERPOINT: Abandon or Reassess? Interpreting Treatment Effects in “Negative” Clinical Trials50
Younger Adults Have Discordant Heart Failure Symptoms49
Durable Mechanical Circulatory Support: The Spring of Hope or the Winter of Despair?46
QT Interval Correction In Left Bundle Branch Areas Pacing (LBBAP)45
PHOSPHOPROTEOMIC INSIGHTS INTO PATHOBIOLOGY AND POTENTIAL DRUG TARGETS IN A PORCINE MODEL OF EXPERIMENTALLY INDUCED PULMONARY VENOUS HYPERTENSION44
Cardiovascular Interplay Between Heart Failure Patients With Concurrent Depression, A Comprehensive Retrospective Analysis44
Outcomes In Patients With Right Ventricular Failure & Preserved Left Ventricular Systolic Function On Short-term Inotropic Support43
Ventricular Assisted Device In Transposition Of Great Arteries: Indications, Outcomes, Hemodynamic Insights42
Cardiac Magnetic Resonance In Patients With Suspectedtachycardia-induced Cardiomyopathy - The Impact Of Lategadolinium Enhancement And Epicardial Fat Tissue40
Association Of Amiodarone With Rvf Post Lvad40
Emerging Adults: a Group Caught in the Middle40
Hospitalization For Acute Kidney Injury In Patients With Heart Failure & Atrial Fibrillation Is Associated With Greater Risk Of Cardiogenic Shock & Major Adverse Cardiovascular Outcomes39
Differences In Lung Fluid Quality Between Decompensated Heart Failure Patients And Covid-19 Patients- Results Of The Impedance-corona Trial39
Symptomatic Heart Failure With Preserved Ejection Fraction: Is It Too Late to Consider Additional Therapies?38
Measuring Clinically Important Changes in Patients With Heart Failure37
No Competition, No Progress37
A Distinction Between Wellness and Resilience37
Table of Contents36
0.33676600456238